MATES

Welcome to the Brand page for “MATES”, which is offered here for Discovery, research, development, engineering, and testing of pharmaceuticals and substances, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders;.

Its status is currently believed to be active. Its class is unavailable. “MATES” is believed to be currently owned by “BIOHAVEN THERAPEUTICS LTD.”

Owner:
BIOHAVEN THERAPEUTICS LTD.
Owner Details
Description:
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders;
Categories: DISCOVERY